Human cytomegalovirus UL144 open reading frame: Sequence hypervariability in low-passage clinical isolates

Journal of Virology

Volumn 73, Issue 12, 1999, Pages 10040-10050

  Lurain, Nell S ^a   Kapell, Kathi S ^a   Huang, Diana D ^a   Short, Jeffery A ^a   Paintsil, Jeanette ^a   Winkfield, Ernest ^a   Benedict, Chris A ^b   Ware, Carl F ^b   Bremer, James W ^a  

^a RUSH MEDICAL COLLEGE   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; TUMOR NECROSIS FACTOR; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CYTOMEGALOVIRUS; GENETIC VARIABILITY; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PHYLOGENY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS INFECTIVITY; VIRUS ISOLATION;

EID: 0032752996     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.12.10040-10050.1999     Document Type: Article

References (57)

1. Altschul, S. F., T. L. Madden, A. A. Schäffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.
2. Bairoch, A., P. Bucher, and K. Hofmann. 1997. The PROSITE database, its status in 1997. Nucleic Acids Res. 25:217-221.
3. Banchereau, J., F. Bazan, D. Blanchard, F. Brière, J. P. Galizzi, C. van Kooten, Y. J. Liu, F. Rousset, and S. Saeland. 1994. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881-922.
4. Benedict, C. A., K. D. Butrovich, N. S. Lurain, J. Corbeil, I. Rooney, P. Schneider, J. Tschopp, and C. F. Ware. 1999. A novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. J. Immunol. 162:6967-6970.
5. Bertin, J., R. C. Armstrong, S. Ottilie, D. A. Martin, Y. Wang, S. Banks, G.-H. Wang, T. G. Senkevich, E. S. Alnemri, B. Moss, M. J. Lenardo, K. J. Tomaselli, and J. I. Cohen. 1997. Death effector domain-containing herpes-virus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. USA 94:1172-1176.
6. Bongarts, A., D. von Laer, C. Vogelberg, K. Ebert, J. van Lanzen, J. Garweg, P. Vaith, F. T. Hufert, O. Haller, and U. Meyer-König. 1996. Glycoprotein B genotype of human cytomegalovirus: distribution in HIV-infected patients. Scand. J. Infect. Dis. 28:447-449.
7. Brukiewicz, R. R., and R. M. Welsh. 1995. Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells. J. Virol. 69:3967-3971.
8. Cha, T.-A., E. Tom, G. W. Kemble, G. M. Duke, E. S. Mocarski, and R. R. Spaete. 1996. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J. Virol. 70:78-83.
9. Chamuleau, M. E. D., I. J. M. ten Berge, P. T. A. Schellekens, J. M. Wilmink, R. Q. Hintzen, and R. A. W. van Lier. 1992. Serum levels of soluble CD27 in renal transplant recipients. Transplantation 54:932-936.
10. Chern, K. C., D. B. Chandler, D. F. Martin, B. D. Kuppermann, R. A. Wolitz, and T. P. Margolis. 1998. Glycoprotein B subtyping of cytomegalovirus (CMV) in the vitreous of patients with AIDS and CMV retinitis. J. Infect. Dis. 178:1149-1153.
11. Chinnaiyan, A. M., K. O'Rourke, G.-L. Yu, R. H. Lyons, M. Garg, D. R. Duan, L. Xing, R. Gentz, J. Ni, and V. M. Dixit. 1996. Signal transduction by DR3, a death domain-containing receptor related to TNRF-1 and CD95. Science 274:990-992.
12. Chou, S., and K. M. Dennison. 1991. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J. Infect. Dis. 163:1229-1234.
13. Chou, S., N. S. Lurain, A. Weinberg, and C. S. Crumpacker. 1999. Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Antimicrob. Agents Chemother. 43:1500-1502.
14. Fries, B. C., S. Chou, M. Boeckh, and B. Torok-Storb. 1994. Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients. J. Infect. Dis. 169:769-774.
15. Gruss, H.-J., J. Duyster, and F. Herrmann. 1996. Structural and biological features of the TNF receptor and TNF ligand superfamilies: interactive signals in the pathobiology of Hodgkin's disease. Ann. Oncol. 7(Suppl. 4): S19-S26.
16. Hillis, D. M., and J. J. Bull. 1993. An empirical test of bootstrapping as a method for assessing confidence in phylogenetic trees. Syst. Biol. 42:182-192.
17. Hu, F.-Q., C. A. Smith, and D. J. Pickup. 1994. Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. Virology 204:343-356.
18. Hu, S., C. Vincenz, M. Buller, and V. M. Dixit. 1997. A novel family of viral death effector domain-containing molecules that inhibit both CD-95- and tumor necrosis factor receptor-1-induced apoptosis. J. Biol. Chem. 272: 9621-9624.
19. Jones, T., and L. Sun. 1997. Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains. J. Virol. 71:2970-2979.
20. Klein, M., K. Schoppel, N. Amrrossiadis, and M. Mach. 1999. Strain-specific neutralization of human cytomegalovirus isolates by human sera. J. Virol. 73:878-886.
21. Lee, H., J. Guo, M. Li, J.-K. Choi, M. DeMaria, M. Rosenzweig, and J. U. Jung. 1998. Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus. Mol. Cell. Biol. 18:5219-5228.
22. Lee, H., J. J. Trimble, D.-W. Yoon, D. Regier, R. C. Desrosiers, and J. U. Jung. 1997. Genetic variation of herpesvirus saimiri subgroup A transforming protein and its association with cellular src. J. Virol. 71:3817-3825.
23. Loparev, V. N., J. M. Parsons, J. C. Knight, J. F. Panus, C. A. Ray, R. M. L. Buller, D. J. Pickup, and J. J. Esposito. 1998. A third distinct tumor necrosis factor receptor of orthopoxviruses. Proc. Natl. Acad. Sci. USA 95:3786-3791.
24. Lurain, N. S. Unpublished data.
25. Lurain, N. S., H. C. Ammons, K. S. Kapell, V. V. Yeldandi, E. R. Garrity, and J. P. O'Keefe. 1996. Molecular analysis of human cytomegalovirus strains from two lung transplant recipients with the same donor. Transplantation 62:497-502.
26. Lurain, N. S., K. S. Kapell, E. Winkfield, J. Paintsil, and J. W. Bremer. 1999. Strain-specific sequence variability of human cytomegalovirus clinical strains, abstr. 11.027. In Abstracts of the 24th International Herpesvirus Workshop.
27. Marks, M., H. Ohno, T. Kirchhausen, and J. Bonifacino. 1997. Protein sorting by tyrosine-based signals: adapting to the Ys and wherefores. Trends Cell Biol. 7:124-128.
28. Massung, R. F., J. J. Esposito, L. I. Liu, J. Qi, T. R. Utterback, J. C. Knight, L. Aubin, T. E. Yuran, J. M. Parsons, V. N. Loparev, N. A. Selivanov, K. F. Cavallaro, A. R. Kerlavage, B. W. J. Mahy, and J. C. Venter. 1993. Potential virulence determinants in terminal regions of variola smallpox virus genome. Nature 366:748-751.
29. Meyer-König, U., M. Haberland, D. von Laer, O. Haller, and F. T. Hufert. 1998. Intragenic variability of human cytomegalovirus glycoprotein B in clinical strains. J. Infect. Dis. 177:1162-1169.
30. Meyer-König, U., C. Vogelberg, A. Bongarts, D. Kampa, R. Delbrück, G. Wolff-Vorbeck, G. Kirste, M. Gaberland, F. T. Hufert, and D. von Laer. 1998. Glycoprotein B genotype correlates with cell tropism in vivo of human cytomegalovirus infection. J. Med. Virol. 55:75-81.
31. Montgomery, R. I., M. S. Warner, B. J. Lum, and P. G. Spear. 1996. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87:427-436.
32. Mosialos, G., M. Birkenbach, R. Yalamanchili, T. VanArsdale, C. Ware, and E. Kieff. 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389-399.
33. Navarro, D., P. Pedro, S. Tugizov, K. Topp, J. La Vail, and L. Pereira. 1993. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology 197:143-158.
34. Page, R. D. M. 1996. TreeView: an application to display phylogenetic trees on personal computers. Comput. Appl. Biosci. 12:357-358.
35. Pan, G., J. Ni, Y.-F. Wei, G.-L. Yu, R. Gentz, and V. M. Dixit. 1997. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277:815-818.
36. Pleskoff, O., C. Tréboute, A. Brelot, N. Heveker, M. Seman, and M. Alizon. 1997. Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Science 276:1874-1878.
37. Prasad, K. V. S., Z. Ao, Y. Yoon, M. X. Wu, M. Rizk, S. Jacquot, and S. R. Schlossman. 1997. CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proc. Natl. Acad. Sci. USA 94:6346-6351.
38. Quinnan, G. V., W. H. Burns, N. Kirmani, A. H. Rook, J. Manischewitz, L. Jackson, G. W. Santos, and R. Saral. 1984. HLA-restricted cytotoxic T lymphocytes are an early immune response and important defense mechanism in cytomegalovirus infections. Rev. Infect. Dis. 6:156-163.
39. Rasmussen, L., C. Hong, D. Zipeto, S. Morris, D. Sherman, S. Chou, R. Miner, W. L. Drew, R. Wolitz, A. Dowling, A. Warford, and T. C. Merigan. 1997. Cytomegalovirus gB genotype distribution differs in human immunodeficiency virus-infected patients and immunocompromised allograft recipients. J. Infect. Dis. 175:179-184.
40. Ray, C. A., R. A. Black, S. R. Kronheim, T. A. Greenstreet, P. R. Sleath, G. S. Salvesen, and D. J. Pickup. 1992. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell 69:597-604.
41. Reyburn, H. T., O. Mandelboim, M. Valés-Gómez, D. M. Davis, L. Pazmany, and J. L. Strominger. 1997. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386:514-517.
42. Rosen, H. R., C. L. Corless, J. Rabkin, and S. Chou. 1998. Association of cytomegalovirus genotype with graft rejection after liver transplantation. Transplantation 66:1627-1631.
43. Schreiber, M., L. Sedger, and G. McFadden. 1997. Distinct domains of M-T2, the myxoma virus tumor necrosis factor (TNF) receptor homolog, mediate extracellular TNF binding and intracellular apoptosis inhibition. J. Virol. 71:2171-2181.
44. Shepp, D. H., M. E. Match, A. B. Ashraf, S. M. Lipson, C. Millan, and R. Pergolizzi. 1996. Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS. J. Infect. Dis. 174:184-187.
45. Sheridan, J. P., S. A. Marsters, R. M. Pitti, A. Gurney, M. Skubatch, D. Baldwin, L Ramakrishnan, C. L. Gray, K. Baker, W. I. Wood, A. D. Goddard, P. Godowski, and A. Ashkenazi. 1997. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277:818-821.
46. Shisler, J., C. Yang, B. Walter, C. F. Ware, and L. Gooding. 1997. The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis. J. Virol. 71:8299-8306.
47. Smith, C. A., T. Farrah, and R. G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76:959-962.
48. α. Virology 223:132-147.
49. Terry-Allison, R. R., R. I. Montgomery, J. D. Whitbeck, R. Xu, G. H. Cohen, R. J. Eisenberg, and P. Spear. 1998. HveA (herpesvirus entry mediator A), a coreceptor for herpes simplex virus entry, also participates in virus-induced cell fusion. J. Virol. 72:5802-5810.
50. Torok-Storb, B., M. Boeckh, C. Hoy, W. Leisenring, D. Myerson, and T. Gooley. 1997. Association of specific cytomegalovirus genotypes with death from myelosuppression after marrow transplantation. Blood 90:2097-2102.
51. Triantos, E., A. W. Boulter, J. C. Leao, L. Di Albert, S. R. Porter, C. M. Scully, W. Birnbaum, N. W. Johnson, and C. G. Teo. 1998. Diversity of naturally occurring Epstein-Barr virus revealed by nucleotide sequence polymorphism in hypervariable domains in the BamHI K and N subgenomic regions. J. Gen. Virol. 79:2809-2817.
52. Vogelberg, C., U. Meyer-König, F. T. Hufert, G. Kirste, and D. von Laer. 1996. Human cytomegalovirus glycoprotein B genotypes in renal transplant recipients. J. Med. Virol. 50:31-34.
53. von Heijne, G. 1990. The signal peptide. J. Membr. Biol. 115:195-201.
54. Wada, K., S. Mizuno, K. Kato, T. Kamiya, and K. Ozawa. 1997. Cytomegalovirus glycoprotein B sequence variation among Japanese bone marrow transplant recipients. Intervirology 48:215-219.
55. Ware, C. F., T. L. VanArsdale, P. D. Crowe, and J. Browning. 1995. The ligands and receptors of the lymphotoxin system. Curr. Top. Microbiol. Immunol, 198:175-218.
56. Zipeto, D., C. Hong, G. Gerna, M. Zavattoni, D. Katzenstein, T. C. Merigan, and L. Rasmussen. 1998. Geographic and demographic differences in the frequency of human cytomegalovirus gB genotypes 1-4 in immunocompromised patients. AIDS Res. Hum. Retroviruses 14:533-536.
57. Zong, J.-C., D. M. Ciufo, D. J. Alcendor, X. Wan, J. Nicholas, P. J. Browning, P. L. Rady, S. K. Tyring, J. M. Orenstein, C. S. Rabkin, I.-J. Su, K. F. Powell, M. Croxson, K. E. Foreman, B. J. Nickoloff, S. Alkan, and G. S. Hayward. 1999. High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations. J. Virol. 73:4156-4170.